To identify the possible cell source of TL1A, first we analyzed specific TL1A mRNA expression in different cell subsets (CD3+, CD14+, CD19+) isolated by FACS from PBMCs of CLL patients and healthy donors. This evidence concerns the gene CD14 and B-cell chronic lymphocytic leukemia.